“Because of ProBioGen´s continuous support and always providing valuable information not only on technical challenges but also urgent issues associated with the project, our teams were able to bring a product from the facility into the clinic as scheduled, within several months here in Japan.”

Chiome Bioscience Inc.
Director, CMC Development

“In ProBioGen, we see a company that values scientific contribution and enables high quality drug development for customers, which ultimately benefits the patients we all serve.”

Celgene Corporation
Senior Director, Biologics Development

“In the midst of an escalating pandemic, ProBioGen successfully managed safety, staffing, and procurement to maintain aggressive timelines for Pionyr´s two first-in-class TME directed afucosylated monoclonal antibodies.”

Pionyr Immunotherapeutics, Inc.
SVP, Technical Operations